Invention for Innovation Programme - Challenge Awards Committee
Contents
The funding committees for the NIHR Invention for Innovation (i4i) Programme are multidisciplinary, comprising academic, clinical and commercial experts, as well as patient and public members. i4i has four committees: two for Product Development Awards (committee A and committee B), one for Challenge Awards, and one for Connect.
Committee members - Challenge Awards 2019
| Name | Position | Organisation | Expertise |
| Professor Nick Lemoine (Chair) | Director | Barts Cancer Institute | I am the Director of Barts Cancer Institute. My groups' primary research interests are in the genomics and molecular pathology of pancreatic cancer and the development of oncolytic virotherapy |
| Ms Jo Smart (Deputy Chair) | Chief Operating Officer | VivoPlex Medical Ltd | A life sciences business executive with over 15 years' experience, Jo is COO of Vivoplex Medical Ltd, a UK medtech SME |
| Mrs Janet Champion | Public Committee Member | N/A | Janet is an experienced HR professional with a long career in the public sector; more recently working for the NHS and in the Charity sector as an independent consultant |
| Mr Chris Chaney | Chief Executive | Chelsea and Westminster Hospitals NHS Foundation Trust | Chris leads the innovation programme at Chelsea and Westminster Hospital Foundation Trust, is a member of the Trust Board and CEO of Trust charity, CW+ |
| Dr Iain Hennessey | Clinical Director of Innovation | Alder Hay Children’s NHS Foundation Trust | Paediatric surgery, surgical simulation and clinical innovation |
| Professor Claire Hulme | Professor of Health Economics | Institute of Health Research, University of Exeter | A health economist whose background lies in range of methodologies including economic evaluation, large data analysis and use of qualitative methods in health economics |
| Mrs Ceila Ingham-Clark | Medical Director for Clinical Effectiveness | NHS England | Medical Director for Professional Leadership and Clinical Effectiveness; previous Trust Medical Director and general surgeon |
| Dr Zarnie Khadjesari | Senior Lecturer in Health Promotion | University of East Anglia | Zarnie is an implementation scientist and digital health researcher in the field of health promotion. She is experienced in both quantitative and qualitative research methods |
| Mrs Anna King | Commercial Director | South London Academic Health Science Network (AHSN) | Financial, commercial and business experience across a wide range of pharmaceutical and healthcare areas, including digital |
| Dr David Kryl | Director of Insight for Wessex AHSN | Wessex Academic Health Science Network (AHSN) | David is responsible for the evaluation strategy of Wessex Academic Health Science Network, with expertise in implementation, research, evaluation, and impact assessment frameworks |
| Dr Sarah Markham | Public Committee Member | Kings College London | Long-term mental health service user with extensive PPI experience spanning more than a decade with both local and national organisations. Academic mathematician and Visiting Researcher at King's College London |
| Miss Fay McCracken | Associate Director | NICE Office for Market Access Accelerated Access Collaborative Secretariat | Over 15 years’ experience in Health Technology Assessment, health economics and market access for all types of life sciences products |
| Mr Stuart Mealing | Associate Director for Health Technology Assessment | York Health Economics Consortium Ltd | Decision analytic modelling, statistical analysis of patient level data (from clinical trials to large real world evidence datasets), Preparation of health technology assessment submission dossiers |
| Mr Steve Morris | CEO | Creo Medical | Steve Morris has over 15 years of experience managing complex projects and programmes in the Defence sector. He has led project teams for the Ministry of Defence, and delivering major projects for the Royal Navy and the British Army. Mr. Morris holds a BScEng and is a member of the IET and the Association for Project Management |
| Mr Sebastian Orton | Partner, Corporate | Penningtons Manches LLP | I am a corporate finance lawyer with specific expertise in equity capital markets and raising finance for companies in the life sciences sector |
| Professor Amar Rangan | Professor of Orthopaedic Surgery | Universities of York and Oxford | Specialist shoulder & elbow surgeon; Experienced in clinical effectiveness and translational research |
| Mr Simon Thorn | Managing Director | Acceleris Capital Limited | Evaluating the financial, corporate and commercial aspects of early stage healthcare propositions from a business viability and investability angle |
| Professor Wendy Tindale | Director | NIHR Devices for Dignity MIC | Involved in Test Beds and experienced in implementation of MedTech |